Davis's Drug Guide
insulin glargine
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
in-su-lin glar-jeen
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Basaglar KwikPen
- Basaglar Tempo Pen
- Lantus
- Lantus SoloStar
- Rezvoglar KwikPen
- Semglee
- Toujeo Max SoloStar
- Toujeo SoloStar
Ther. Class.
Pharm. Class.
pancreatics
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Insulin Glargine." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51868/6/insulin_glargine.
Vallerand AHA, Sanoski CAC, . Insulin glargine. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51868/6/insulin_glargine. Accessed April 19, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Insulin glargine. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51868/6/insulin_glargine
Vallerand AHA, Sanoski CAC, . Insulin Glargine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 19]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51868/6/insulin_glargine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - insulin glargine
ID - 51868
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51868/6/insulin_glargine
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -
